Steve E. Krognes - Director at Denali Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
DNLI on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Steve E. Krognes since 11 Feb 2025

Holdings reported by Steve E. Krognes for Denali Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 781,797 $12,852,742 $16.44 03 Jun 2025 Indirect
Common Stock 31,794 $522,693 $16.44 03 Jun 2025 Direct
Stock Option (right to buy) 18,111 03 Jun 2025 Direct Common Stock

Transactions reported by Steve E. Krognes for Denali Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.